ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKCLuke H. Stockwin(Leidos (United States)), Dianne L. Newton(Leidos (United States))BMC CancerFebruary 20, 200910.1186/1471-2407-9-63Cited by 28SaveCiteExport RISWatch citationsRelated PapersOxyphenisatin acetate (<scp>NSC</scp>59687) triggers a cell starvation response leading to autophagy, mitochondrial dysfunction, and autocrine<scp>TNF</scp>α‐mediated apoptosis|Cancer Medicine|2013|17UNC2025 , a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor|Figshare|2020|7